1 Market Overview
1.1 Afatinib Introduction
1.2 Market Analysis by Type
1.2.1 30mg Tables
1.2.2 40mg Tables
1.2.3 50mg Tables
1.2.4 25mg Tables
1.2.5 20mg Tables
1.2.6 Other
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Drug Center
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2015-2025)
1.4.1.2 Canada Market States and Outlook (2015-2025)
1.4.1.3 Mexico Market States and Outlook (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2015-2025)
1.4.2.2 France Market States and Outlook (2015-2025)
1.4.2.3 UK Market States and Outlook (2015-2025)
1.4.2.4 Russia Market States and Outlook (2015-2025)
1.4.2.5 Italy Market States and Outlook (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2015-2025)
1.4.3.2 Japan Market States and Outlook (2015-2025)
1.4.3.3 Korea Market States and Outlook (2015-2025)
1.4.3.4 India Market States and Outlook (2015-2025)
1.4.3.5 Southeast Asia Market States and Outlook (2015-2025)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2015-2025)
1.4.4.2 Egypt Market States and Outlook (2015-2025)
1.4.4.3 Saudi Arabia Market States and Outlook (2015-2025)
1.4.4.4 South Africa Market States and Outlook (2015-2025)
1.4.4.5 Turkey Market States and Outlook (2015-2025)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Boehringer Ingelheim
2.1.1 Business Overview
2.1.2 Afatinib Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Boehringer Ingelheim Afatinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.2 Hengrui Medicine
2.2.1 Business Overview
2.2.2 Afatinib Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Hengrui Medicine Afatinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.3 Beacon Pharma
2.3.1 Business Overview
2.3.2 Afatinib Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Beacon Pharma Afatinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
3 Global Afatinib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2019)
3.1 Global Afatinib Sales and Market Share by Manufacturer (2017-2019)
3.2 Global Afatinib Revenue and Market Share by Manufacturer (2017-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Afatinib Manufacturer Market Share in 2019
3.3.2 Top 6 Afatinib Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Afatinib Market Analysis by Regions
4.1 Global Afatinib Sales, Revenue and Market Share by Regions
4.1.1 Global Afatinib Sales and Market Share by Regions (2015-2019)
4.1.2 Global Afatinib Revenue and Market Share by Regions (2015-2019)
4.2 North America Afatinib Sales and Growth Rate (2015-2019)
4.3 Europe Afatinib Sales and Growth Rate (2015-2019)
4.4 Asia-Pacific Afatinib Sales and Growth Rate (2015-2019)
4.5 South America Afatinib Sales and Growth Rate (2015-2019)
4.6 Middle East and Africa Afatinib Sales and Growth Rate (2015-2019)
5 North America Afatinib by Country
5.1 North America Afatinib Sales, Revenue and Market Share by Country
5.1.1 North America Afatinib Sales and Market Share by Country (2015-2019)
5.1.2 North America Afatinib Revenue and Market Share by Country (2015-2019)
5.2 United States Afatinib Sales and Growth Rate (2015-2019)
5.3 Canada Afatinib Sales and Growth Rate (2015-2019)
5.4 Mexico Afatinib Sales and Growth Rate (2015-2019)
6 Europe Afatinib by Country
6.1 Europe Afatinib Sales, Revenue and Market Share by Country
6.1.1 Europe Afatinib Sales and Market Share by Country (2015-2019)
6.1.2 Europe Afatinib Revenue and Market Share by Country (2015-2019)
6.2 Germany Afatinib Sales and Growth Rate (2015-2019)
6.3 UK Afatinib Sales and Growth Rate (2015-2019)
6.4 France Afatinib Sales and Growth Rate (2015-2019)
6.5 Russia Afatinib Sales and Growth Rate (2015-2019)
6.6 Italy Afatinib Sales and Growth Rate (2015-2019)
7 Asia-Pacific Afatinib by Country
7.1 Asia-Pacific Afatinib Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Afatinib Sales and Market Share by Country (2015-2019)
7.1.2 Asia-Pacific Afatinib Revenue and Market Share by Country (2015-2019)
7.2 China Afatinib Sales and Growth Rate (2015-2019)
7.3 Japan Afatinib Sales and Growth Rate (2015-2019)
7.4 Korea Afatinib Sales and Growth Rate (2015-2019)
7.5 India Afatinib Sales and Growth Rate (2015-2019)
7.6 Southeast Asia Afatinib Sales and Growth Rate (2015-2019)
8 South America Afatinib by Country
8.1 South America Afatinib Sales, Revenue and Market Share by Country
8.1.1 South America Afatinib Sales and Market Share by Country (2015-2019)
8.1.2 South America Afatinib Revenue and Market Share by Country (2015-2019)
8.2 Brazil Afatinib Sales and Growth Rate (2015-2019)
8.3 Argentina Afatinib Sales and Growth Rate (2015-2019)
8.4 Colombia Afatinib Sales and Growth Rate (2015-2019)
9 Middle East and Africa Afatinib by Countries
9.1 Middle East and Africa Afatinib Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Afatinib Sales and Market Share by Country (2015-2019)
9.1.2 Middle East and Africa Afatinib Revenue and Market Share by Country (2015-2019)
9.2 Saudi Arabia Afatinib Sales and Growth Rate (2015-2019)
9.3 Turkey Afatinib Sales and Growth Rate (2015-2019)
9.4 Egypt Afatinib Sales and Growth Rate (2015-2019)
9.5 Nigeria Afatinib Sales and Growth Rate (2015-2019)
9.6 South Africa Afatinib Sales and Growth Rate (2015-2019)
10 Global Afatinib Market Segment by Type
10.1 Global Afatinib Sales, Revenue and Market Share by Type (2015-2019)
10.1.1 Global Afatinib Sales and Market Share by Type (2015-2019)
10.1.2 Global Afatinib Revenue and Market Share by Type (2015-2019)
10.2 30mg Tables Sales Growth and Price
10.2.1 Global 30mg Tables Sales Growth (2015-2019)
10.2.2 Global 30mg Tables Price (2015-2019)
10.3 40mg Tables Sales Growth and Price
10.3.1 Global 40mg Tables Sales Growth (2015-2019)
10.3.2 Global 40mg Tables Price (2015-2019)
10.4 50mg Tables Sales Growth and Price
10.4.1 Global 50mg Tables Sales Growth (2015-2019)
10.4.2 Global 50mg Tables Price (2015-2019)
10.5 25mg Tables Sales Growth and Price
10.5.1 Global 25mg Tables Sales Growth (2015-2019)
10.5.2 Global 25mg Tables Price (2015-2019)
10.6 20mg Tables Sales Growth and Price
10.6.1 Global 20mg Tables Sales Growth (2015-2019)
10.6.2 Global 20mg Tables Price (2015-2019)
10.7 Other Sales Growth and Price
10.7.1 Global Other Sales Growth (2015-2019)
10.7.2 Global Other Price (2015-2019)
11 Global Afatinib Market Segment by Application
11.1 Global Afatinib Sales Market Share by Application (2015-2019)
11.2 Hospital Sales Growth (2015-2019)
11.3 Clinic Sales Growth (2015-2019)
11.4 Drug Center Sales Growth (2015-2019)
11.5 Other Sales Growth (2015-2019)
12 Afatinib Market Forecast (2020-2025)
12.1 Global Afatinib Sales, Revenue and Growth Rate (2020-2025)
12.2 Afatinib Market Forecast by Regions (2020-2025)
12.2.1 North America Afatinib Market Forecast (2020-2025)
12.2.2 Europe Afatinib Market Forecast (2020-2025)
12.2.3 Asia-Pacific Afatinib Market Forecast (2020-2025)
12.2.4 South America Afatinib Market Forecast (2020-2025)
12.2.5 Middle East and Africa Afatinib Market Forecast (2020-2025)
12.3 Afatinib Market Forecast by Type (2020-2025)
12.3.1 Global Afatinib Sales Forecast by Type (2020-2025)
12.3.2 Global Afatinib Market Share Forecast by Type (2020-2025)
12.4 Afatinib Market Forecast by Application (2020-2025)
12.4.1 Global Afatinib Sales Forecast by Application (2020-2025)
12.4.2 Global Afatinib Market Share Forecast by Application (2020-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
